Abstract. The purpose of this study was to assess the feasibility of use of gadophrin-2 to trace intravenously injected human hematopoietic cells in athymic mice, employing magnetic resonance (MR) imaging, optical imaging (OI), and fluorescence microscopy. Mononuclear peripheral blood cells from GCSF-primed patients were labeled with gadophrin-2 (Schering AG, Berlin, Germany), a paramagnetic and fluorescent metalloporphyrin, using established transfection techniques with cationic liposomes. The labeled cells were evaluated in vitro with electron microscopy and inductively coupled plasma atomic emission spectrometry. Then, 1×10 6 -3×10 8 labeled cells were injected into 14 nude Balb/c mice and the in vivo cell distribution was evaluated with MR imaging and OI before and 4, 24, and 48 h after intravenous injection (p.i.). Five additional mice served as controls: three mice were untreated controls and two mice were investigated after injection of unlabeled cells. The contrast agent effect was determined quantitatively for MR imaging by calculating signal-to-noise-ratio (SNR) data. After completion of in vivo imaging studies, fluorescence microscopy of excised organs was performed.
Introduction
Bone marrow transplantation using hematopoietic stem cells provides established therapeutic approaches for otherwise fatal diseases such as leukemias, lymphomas, and metastasized carcinomas [1, 2, 3, 4] . It is anticipated that new directions in therapy involving the replacement of defective or injured tissue by stem cell-derived functional tissue will improve preventive and therapeutic care of many devastating diseases, e.g., Parkinson's disease, Alzheimer's dementia, and diabetes [1, 2, 3, 4] . However, the mechanisms that regulate homing, engraftment, and proliferation of marrow-derived stem cells into the bone marrow and other organs are still poorly understood. In addition, the integration of the transplanted cells into the host parenchyma is difficult to evaluate in vivo since they cannot be distinguished on the basis of their morphological properties. Thus, cell labeling procedures might assist in identifying and tracing the fate of the transplanted cells. To allow depiction of transplanted cells in vivo using imaging modalities, several methods have been designed to label stem cells with fluorescent dyes or contrast agents prior to administration [5, 6, 7, 8, 9, 10, 11] . However, the optimal imaging technique for in vivo tracking of the transplanted cells is still under debate.
Bifunctional contrast agents, which could be detected at the same time by magnetic resonance (MR) imaging, optical imaging (OI), and fluorescence microscopy, would allow integration of the advantages of these conceptually highly different imaging techniques [8, 12, 13] : the high three-dimensional anatomical resolution provided in vivo by MR imaging, the high sensitivity provided by OI and detection at the cellular level provided by fluorescence microscopy. Furthermore, the limitations of each technique, such as the low sensitivity of MR imaging, the limited anatomical background information obtained with OI, and the ex vivo information obtained with fluorescence microscopy, could be compensated for by the other techniques. Thus, features invisible with one of these modalities could be rendered by the others.
Gadophrin-2 is a porphyrin-based contrast agent, composed of an aromatic ring, which causes fluorescence, and covalently bound paramagnetic gadolinium chelates, which decrease T1 relaxation times of target tissues [14] . The resulting MR signal enhancement of intravenously administered gadophrin-2 has been extensively investigated [14, 15, 16, 17] , whereas little attention has so far been paid to its coexistent fluorescence capabilities. Thus, the purpose of this study was to investigate the concurrent bifunctional properties of gadophrin-2 as a contrast agent for MR imaging, OI, and fluorescence microscopy and potential applications of this agent for multimodality stem cell tracking studies in an established murine xenotransplant model.
Materials and methods

Cell suspensions
Human peripheral blood cells were isolated by leukapheresis from nine patients who underwent stem cell mobilization by treatment with 10 µg/kg granulocyte colony-stimulating factor for 12-15 days (Table 1) . The study was approved by the Committee on Medical Ethics of the Technical University of Munich and consent was given by all patients. Hematopoietic mononuclear cells were isolated from the blood samples using Ficoll density centrifugation (d=1.077 g/ml, Biochrom, Berlin, Germany). After centrifugation at 1,000 g for 20 min, the mononuclear interphase cells were collected and red cells were lysed using Ortholysis reagent (Ortho). The resulting cells were washed twice in HF/2+ [Hank's balanced salt solution (InvitroGen), supplemented with 2% FCS and 10 mM HEPES (Gibco)]. Prior to the labeling procedure, the cells were again centrifuged, and the cell pellet was resuspended with 1 ml of Dulbecco's Modified Eagle Medium (DMEM, Gibco). Cells were counted by two independent observers (H.E.D., M.R.) in a cell counter prior to each experiment.
Contrast medium
Gadophrin-2 (kindly provided by H.J. Weinmann; Schering AG, Berlin, Germany) is composed of a porphyrin ring and two covalently linked gadolinium chelates ( Fig. 1 ) [14] . It has a molecular weight of 1,759.38 Da. The r 1 relaxivity (Plasma, 20 MHz, 37°C) is 19.8±0.1 l mmol −1 s −1 and the r 2 relaxivity (Plasma, 20 MHz, 37°) is 30.0±1.0 l mmol −1 s −1 . The porphyrin ring provides fluorescence of the agent with an excitation of 499 nm and a maximal emission at 617 nm. For this study, gadophrin-2 was supplied as a solution with a concentration of 25 mmol Gd per liter. Due to its negative net charge, gadophrin-2 could be encapsulated with positively charged liposomes using established transfection techniques as described in detail previously [6] . For this study, 20 µl of liposome formulation (Lipofectin, Life Technologies, Gibco BRL), containing 1:1 cationic lipid N- [1-(2,3-dioleyloxy) propyl]-N,N,Ntrimethylammonium chloride (DOTMA) and dioleoyl phosphatidylethanolamine (DOPE), was suspended with 22.5 µl (0.56 mmol) gadophrin-2 and this contrast agent formulation was subsequently incubated with samples of 1×10 6 mononuclear cells in 800 µl DMEM in a CO 2 incubator at 37°C for 2 h. With this procedure, two to four liposomes associate with a single contrast agent molecule, and the lipid complex fuses with the cell plasma membrane and delivers the contrast agent to the cell cytosol [18] .
In vitro studies
Initially, a series of 11 dilutions of gadophrin-2 (from 600 to 6 nmol Gd/ml) as well as normal saline as a control were investigated with MR imaging and OI. Then, 1×10 6 mononuclear peripheral blood cells, labeled with gadophrin-2 as described above, were centrifuged and three sets of cell probes each were investigated with MR, OI, and fluorescence microscopy.
Cell viability was determined by trypan blue exclusion. Viability experiments were performed at least three times for labeled and unlabeled cells by an independent observer (R.A.J.O.), who was blinded to the labeling procedure.
Electron microscopy was performed for gadophrin-2 labeled mononuclear cells and unlabeled controls. The cell probes were fixed in 3% glutaraldehyde/cocadylate buffer overnight, desiccated, embedded in Epon (artificial resin), and processed for electron microscopy. The cell probes were evaluated unstained, i.e., without uranyl or lead supplement, in order to prevent false positive findings. Electron microscopy was performed using a Zeiss EM 10 electron microscope at 60-80 kV. Inductively coupled plasma atomic emission spectrometry (ICP-AES) was performed in 10 6 gadophrin-2 labeled hematopoietic cells to determine the gadolinium concentration within the transplanted cells. This method has a repeated sensitivity of less than 1 ppm.
In vivo studies
The study was approved by the committee on animal research responsible for our institution. Fourteen 12-week-old nude Balb/ c-AnNCrl mice were examined with MR imaging and OI before and 10 min (n=4), 4 h (all), 24 h (n=10), and 48 h (n=4) after intravenous injection of 1×10 6 -3×10 8 gadophrin-labeled hematopoietic cells. Five additional mice underwent the same imaging procedures as controls: three mice served as untreated controls, and two mice were investigated after intravenous injection of 1×10 7 unlabeled cells. For the cell injection, the animals were anesthetized with ether. For the imaging procedures (MRI, OI), a combination of 0.5 mg/kg medetomidin (Dormitor), 5 mg/kg midazolam (Dormicum), and 0.05 mg/kg fentanyl (Fentanyl) was administered intraperitoneally to induce anesthesia, and 2.5 mg/kg atipamezol (Antisedan), 0.5 mg/kg flumazenil (Anexate), and 1.2 mg/kg naloxone (Narcanti) were given as antagonists to wake the animals after the procedures. For tissue analysis, animals were sacrificed after the imaging procedures at 4 h p.i. (n=2), 24 h p.i. (n=5), or 48 h p.i. (n=4) by intracardial injection of an overdose of Narcoren (pentobarbital). Specimens from the liver, spleen, lungs, and thyroid as well as bone marrow from the spine and femur were evaluated with OI, then frozen at −80°C and processed for fluorescence microscopy.
Magnetic resonance imaging
MR imaging was performed using a clinical 1.5-Tesla MR scanner (Philips ACS Intera, Best, The Netherlands) and a dedicated birdcage coil for high-resolution MR imaging (Medical Advances, Milwaukee, WI, USA).
In vitro studies. Test tubes with centrifuged cell pellets were placed in a water-containing plastic container. R1 relaxation rates of labeled cells and unlabeled controls were measured with a mixed inversion recovery (IR)-spin echo (SE) sequence, initiated with an IR experiment with a repetition time (TR) of 5,000 ms, an echo time (TE) of 18 ms, and an inversion time (TI) of 600 ms, followed by an SE experiment with a TR of 600 ms and a TE of 24 ms. The R1 relaxation times of the labeled cells were subsequently derived from T1 maps, which were calculated by the scanner software. R2* relaxation rates of the cells were measured with a T2*-FFE-EPI sequence with a flip angle α of 90°, a TR of 2,000 ms, and 20 increasing TEs from 4 to 36 ms. Both sequences were acquired with a field of view (FOV) of 160×48 mm, a matrix of 256 2 pixels, and a slice thickness of 1.5 mm. The multiple echo T2*-FFE-EPI images were transferred to a personal computer running a Linux operating system. R2* relaxation rates were calculated from the negative slope of the logarithm of the signal intensities as described previously [6] using a dedicated IDL program (Interactive Data Language by Research Systems, Boulder, CO, USA).
In vivo studies. For the in vivo studies, the animals were placed prone in the coil and evaluated with coronal T1-weighted 3D FFE 40°/25/2.7 (α/TR/TE) sequences with a FOV of 100×80 mm, a 512 2 pixel matrix, two acquisitions, and an effective slice thickness of 400 µm. The in-plane spatial resolution of the MR images was 200×150 µm. Liver and spleen could be well depicted on the coronal images. For evaluation of the bone marrow, the 3D data sets were reconstructed along the long axis of the femur and the spine. Average signal intensities (SI) of liver, spleen, and bone marrow were measured by one observer using operator-defined regions of interest (ROIs). The size of the ROIs depended on the cell pellets or organ diameter, with a minimum of 30 pixels per region. Signal-to-noise ratios were calculated by correction of SI data by the image noise (random fluctuations in signal intensity), which was measured in the background anterior to the depicted object [19] : ....SNR = SI target organ /background noise.
Optical imaging
OI was performed using a commercially available high-resolution optical imager (Hamamatsu ORCA II-ER, Herrsching, Germany), providing more than 70% quantum efficiency, an 80-dB dynamic range and less than 4e-read out noise (rms). Images were obtained using a −60°C Peltier-cooled digital black and white camera with 1,280 (H) × 1,024 (V) effective pixel resolution. For fluorescence excitation, a CF-1000 lamp (Illumination Technologies, USA) was used. The lamp setup was slightly modified from its original version and included a 25-nm excitation bandpass filter (500 nm, Eosin, Sp. gold) for gadophrin. The light was led into the dark box (Unit One, USA) by an optical fiber. To distribute the light as homogeneously as possible within the FOV, the light outputs were arranged in a ring structure. For fluorescence detection, a dedicated 40-mm emission bandpass filter (617 nm, TRITC) was used. The nude mice were subsequently placed prone and supine into the imager, cell probes were placed in microtiter plates, and postmortem excised organs were placed on black cardboard. Acquisition times were 100-700 ms. Hamamatsu simple PCI software was used for image processing. Bright field images were merged with the corresponding fluorescence images and the obtained calibrated light emission was subsequently transformed to pseudo-colors.
Fluorescence microscopy Deparaffinated specimens of mouse tissues were sectioned in 2-µm-thick slices and cell nuclei were stained with diamidino-2-phenylindole (DAPI, BIOMOL Research Laboratories, Plymouth, USA) at a dilution of 1:10,000 and an incubation time of 1 min. Afterwards, the tissue slices were washed three times with phosphate-buffered saline (PBS, pH=7.4) and covered with glass using FluorSave (Merck, Darmstadt, Germany). Then, cell-associated fluorescence was determined by fluorescence microscopy using a Zeiss Axioplan 2 microscope (Jena, Germany). A standard fluorescein filter was used to detect green fluorescence, a rhodamine filter was used to detect red fluorescence, and a UV filter was applied to detect blue fluorescence.
Statistical analysis R1 relaxation rates, ∆SI data, and fluorescence data were presented as means and standard deviations of the means. To compare differences in quantitative data at different time points before and after injection of gadophrin-targeted cells in the same animals, a two-tailed paired t test was used. Statistical significance was assigned if P<0.05. All statistical computations were processed using Statview 4.1 software (Abacus, Berkeley, CA, USA).
Results
Gadophrin-2: MR signal intensity and OI fluorescence
Dilution series of gadophrin-2 revealed positive signal enhancement of the contrast agent on T1-weighted FFE images: this signal enhancement linearly declined down to a concentration of 20 nmol Gd/ml (Fig. 2) . Lower concentrations of the contrast agent could not be detected with MR imaging. With OI, a higher sensitivity could be achieved: fluorescence of the contrast agent could be detected down to a minimal concentration of 2 nmol Gd/ml (Fig. 2) . However, OI revealed a nonlinear relationship between contrast agent concentration and fluorescence: maximal fluorescence was observed at 75 nmol Gd/ml, whereas higher and lower concentrations caused declining fluorescence. The diminished fluorescence with rela- Fig. 2 . Dilution series of decreasing concentrations of 600 to 6 nmol Gd/ml gadophrin-2 and a control sample of normal saline, imaged with T1-weighted fast field echo MR imaging (left) and OI (right). MR depicted a positive signal enhancement down to a minimal concentration of 20 nmol Gd/ml, while OI depicted fluorescence down to a minimal concentration of 0.2 nmol Gd/ml tively high contrast agent concentrations was most likely due to self-quenching effects.
Cell viability, electron microscopy, and labeling efficiency
After 2 h of incubation with gadophrin-2 liposomes, the cell viability of the labeled cells (87%±7%) was slightly, but not significantly, lower compared with unlabeled controls (94%±5%; P=0.242). Electron microscopy did not reveal any structural changes due to the labeling procedure (Fig. 3) . The contrast agent was internalized into the cells by endocytosis and subsequently accumulated in lysosomes in the cytoplasm and not in the nucleus (Fig. 3) . ICP-AES revealed an internalization of 31.555 nmol Gd per 10 6 gadophrin-2 labeled cells. No detectable gadolinium was found in unlabeled control cells.
In vitro studies of gadophrin-2 labeled cells
OI and fluorescence microscopy revealed a strong fluorescence of gadophrin-2 labeled cells and no fluorescence of controls (Fig. 4) . In addition, the gadophrin-2 labeled cells exhibited a strong and positive signal en- hancement on T1-weighted MR images (Fig. 5) . Consequently, R1 relaxation rates of gadophrin-2 labeled cells (1.25±0.19 s −1 ) were significantly higher than those of unlabeled controls (0.55±0.07 s −1 ; P=0.009), whereas R2* relaxation rates were not significantly different before (61.83±6.63 s −1 ) and after (85.27±12.47 s −1 ; P=0.167) the labeling procedure.
In vivo distribution of gadophrin-2 labeled cells
Two animals, which received intravenous injections of 1×10 6 cells, demonstrated a detectable fluorescence signal with OI, but no visible changes in MR signal intensity. All 12 other animals, which received 1×10 7 -3×10 8 labeled cells, showed visible fluorescence and signal changes on OI and MR imaging, respectively. Within this range of 1×10 7 -3×10 8 injected cells, no significant correlation was found between the number of transplanted cells and quantitative MR enhancement data of the host organs (P>0.05). Directly after cell injection, OI demonstrated increased fluorescence of the lungs, apparently as a function of transient pulmonary cell accumulation (Fig. 6) . MR imaging revealed no detectable signal changes (Fig. 7) . At 4 h post injection (p.i.), OI fluorescence and MR signal enhancement were noted in liver, spleen, and thyroid gland, apparently as a function of cell accumulation in these organs. MR-derived quantitative SNR data increased significantly in these organs (Table 2, P<0.05). OI additionally depicted persistent fluorescence of the lungs and fluorescence of the vertebrae, the pelvis, and femora (Fig. 6) . At 24 h, OI and MR imaging respectively depicted fluores- cence and enhancement of femoral and pelvic bone marrow, indicating homing of the transplanted cells to these organs (Figs. 6, 7) . Corresponding MR-derived SNR data for the bone marrow were significantly increased compared with imaging studies at previous time points (Table 2, P<0.05). OI detected additional cell accumulations in the vertebrae (Fig. 7) . At 48 h p.i., no further changes in OI fluorescence or MR signal intensities occurred. Control animals, which received either no cells or unlabeled cells, did not reveal any detectable fluorescence or signal intensity changes in organs on subsequent OI or MR studies.
Investigations of postmortem excised organs
OI of excised organs showed time-dependent changes in fluorescence of lungs, liver, spleen, thyroid gland, and bone marrow, which generally corresponded to the results of the in vivo studies (Fig. 8) . However, the fluo- rescence of the organs was stronger ex vivo than in vivo, apparently due to emission light absorption in surrounding tissues in vivo. Thus, decreasing fluorescence of lung and liver and increasing fluorescence of the bone marrow at 24 and 48 h p.i. were better depicted ex vivo (Fig. 8) . Corresponding fluorescence microscopy studies confirmed the distribution of gadophrin-2 labeled cells to the described target organs (Fig. 9) .
Discussion
Data showed that gadophrin-2 is a bifunctional contrast agent suited not only for MR imaging [14] but also for OI and fluorescence microscopy. Thus, in vivo cell tracking studies with gadophrin-2 as a cell marker may integrate the advantages of the individual imaging techniques: OI can provide an overview of the general in vivo distribution of all transplanted major and minor cell subpopulations while MR imaging can specify the accumulation of major cell populations in host organs with submillimeter anatomical resolution. It is of note that MR imaging provides three-dimensional data sets as opposed to the two-dimensional OI surface data sets, and thereby localizes transplanted cells more exactly and more deeply within tissues. In vivo findings obtained by OI and MR imaging can be subsequently confirmed at a cellular level by fluorescence microscopy of biopsy specimens or postmortem excised organs, providing direct visualization of labeled donor cells in host tissues without the need for antibodies or co-localization of an antibody with the contrast agent. Alternative attempts at MR contrast agents designed to combine the advantages of fluorescence and MR imaging techniques have been described previously [8, 12, 13] . These comprised the lanthanide chelators DTPA and DOTA, which were bound to gadolinium and covalently attached to fluorescent dyes [8, 13] , and arginyl peptides, which were cross-linked to magnetic nanoparticles and attached to the indocyanine dye Cy 5.5 [12] .
A potential advantage of our labeling technique compared with the above-mentioned alternative bifunctional contrast agents is that gadophrin-2 accumulates only in the cytoplasm of the labeled cells, whereas at least the peptide-based contrast agents are known to accumulate in the cell nucleus as well [12] , where they could cause potential interactions with the DNA. The cyanine dyes in particular could cause toxic effects to the cell nucleus [20] . In addition, the use of gadolinium-based MR contrast agents (like gadophrin-2) may be preferable to iron oxide-based MR contrast agents for the design of bifunctional probes, as the attachment of fluorescein to magnetic iron oxide nanoparticles can be associated with a profound quenching effect due to nonradiative energy transfer or collisions between the dye and the iron oxide [12] . Though we also observed a quenching effect of gadophrin-2 in vitro (Fig. 2 ), this occurred with contrast . The transplanted, labeled cells (arrows) can be delineated by green fluorescence using a standard fluorescein filter (A), by red fluorescence using a rhodamine filter (B), and by yellow fluorescence (C) using both filters. Cell nuclei are displayed blue by DAPI agent concentrations that exceeded the concentrations achieved in vivo [22, 23, 24] .
The fluorescence of gadophrin-2 covered a green-red light spectrum, which was more favorable compared with the spectrum covered by green fluorescent protein [21] because the background signal and the apparent interaction with hemoglobin were considerable smaller with gadophrin-2. It is worthy of note that previous porphyrin formulations provided fluorescence with an infrared spectrum. These formulations, however, were associated with a higher toxicity as compared with subsequently developed probes like gadophrin-2. Newgeneration porphyrins, like gadophrin-3, on the other hand, provide fluorescence of markedly lower intensity compared with gadophrin-2, making them inadequate for bifunctional studies [own unpublished data, 2002].
The fluorescence obtained from gadophrin-2 could not be quantified because of the following general limitations of this imaging method [21] :
1. Light is scattered and absorbed in tissues. Both the excitation light and the emission light are attenuated by a factor of 2. The amount of light detected depends on the depth, thickness, composition, and density of the evaluated tissues. 2. Light excitation is never homogeneous. Thus, intraand interindividual variabilities had to be considered due to the well plate and slight differences in the positioning of the animals. 3. The obtained images were planar and surface weighted. 4. There is always a certain background fluorescence, which would have to be subtracted.
Thus, OI should be considered as a highly sensitive, fast, and easy applicable modality for cell detection, while other imaging methods, such as MR imaging, may be advantageous in providing 3D associations with anatomy and data quantification. Hematopoietic cell labeling with gadophrin-2 provided reliable identification of transplanted human donor cells in the murine target organs by OI, MR imaging, and fluorescence microscopy. Within the range of 1×10 7 -3×10 8 administered gadophrin-2 labeled human hematopoietic progenitor cells, no significant correlation was found between the number of transplanted cells and the quantitative MR enhancement data of the host organs. Standard errors in the results of cell countings by the cell counter and MR signal intensity measurements along with the well-known interindividual variability in the in vivo distribution of intravenously injected cells to as many as 16 different organs may have caused this insensitivity of our imaging method to minor variations in the applied cell number [22, 23, 24, 25, 26] .
The vitality of the investigated cells was not impaired by labeling with gadophrin-2, and the in vivo distribution of intravenously injected gadophrin-2 labeled cells in mice was not different compared to previous investigations with no or different cell labeling procedures [5, 22, 23, 24, 25] . While the distribution of intravenously injected cells to liver, spleen, and bone marrow has also been demonstrated in vivo with other MR techniques [25] , our combined OI and MR cell tracking technique provided additional information: Shortly after intravenous injection, a major population of transplanted cells accumulated in the lung. This observation is in accordance with the literature [26] , but, to the best of our knowledge, has not previously been depicted by an in vivo imaging technique.
In conclusion, the porphyrin-based gadolinium compound gadophrin-2 proved to be suited as a bifunctional contrast agent for in vitro labeling and in vivo tracking of transplanted stem cells using MR imaging, OI, and fluorescence microscopy. The use of this bifunctional agent allows for the integration of MR imaging's submillimeter resolution and OI's high sensitivity, and enables direct visualization of host tissue with fluorescence microscopy without the need for antibodies. The ability to trace the in vivo cell distribution simultaneously with these different techniques may improve our understanding of how stem cells mediate recovery of injured organs, and ultimately cell tracking with gadophrin-2 may be applied as an important method for serial assessments of the transplantation procedure.
